Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The new drug delivery system effectively targets lung cancer cells.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Mesenchymal stem cells could help treat diabetes and its complications by improving insulin function and reducing inflammation.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Combining metformin with myo-inositol is more effective for treating PCOS than metformin alone.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Baricitinib shows promise in treating severe hair loss.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Ruxolitinib can help regrow hair in severe alopecia areata.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Alpinetin helps grow hair by turning on hair stem cells and is safe for use.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Baricitinib helps patients with severe alopecia areata regrow hair.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.